The Effects of Two Different Treatment Protocols on Shoulder Function, Quality of Life, and Ultrasound Parameters in Patients With Frozen Shoulder
NCT ID: NCT05956171
Last Updated: 2023-10-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
50 participants
INTERVENTIONAL
2023-10-01
2024-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Is hydrodilatation better than intraarticular corticosteroid injection?
* Is there any prognostic factors that will help clinicians guide their decision making when choosing between these two treatments?
Participans will receive an injection(cortcosteroid and local anesthetics alone or with hydrodilatation-corticosteroid and local anesthetics plus sterile saline solution) and then they will follow a rehabilitation program.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ultrasound Guided Shoulder Anterior Capsular Infiltration Plus Hydrodilatation With Steroid Versus Hyalase in Patients With Frozen Shoulder
NCT06129006
The Efficacy of Suprascapular Nerve Radiofrequency and Intra-articular Steroid Injection in Frozen Shoulder Treatment
NCT06778577
Comparison Between Subacromial Ultrasound Guided and Systemic Steroid Injection for Frozen Shoulder
NCT04931511
Effect of Ultrasound-guided Suprascapular Nerve Block Versus Intra-articular Corticosteroid Injection for Frozen Shoulder
NCT03515278
Suprascapular Nerve Block in the Management of Patients Diagnosed With Adhesive Capsulitis
NCT07097571
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ultrasound Guided Hydrodilatation with corticosteroid injection
15 ml intra-articular injection to shoulder via anterior approach under ultrasound guidance
Drugs:
* betamethasone dipropionate/ betamethasone sodium phosphate(diprospan) (5 mg+2mg/ml) (1 ml)
* prilocaine hydrochloride %2 (4 ml)
* Sodium chloride %0,9 (10 ml)
Ultrasound Guided Hydrodilatation with corticosteroid injection
15 ml intra-articular injection to shoulder via anterior approach under ultrasound guidance
Blind intra-articular corticosteroid injection
5 ml intra-articular blind injection to shoulder via posterior approach
Drugs:
* betamethasone dipropionate/ betamethasone sodium phosphate(diprospan) (5 mg+2mg/ml) (1 ml)
* prilocaine hydrochloride %2 (4 ml)
Intra-articular corticosteroid injection
5 ml blind intra-articular corticosteroid injection
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intra-articular corticosteroid injection
5 ml blind intra-articular corticosteroid injection
Ultrasound Guided Hydrodilatation with corticosteroid injection
15 ml intra-articular injection to shoulder via anterior approach under ultrasound guidance
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Agree to participate in the study
* Having the opportunity to follow up for at least 3 months
Exclusion Criteria
* History of shoulder injection in the last 3 months
* Having diabetes mellitus
* Presence of comorbidities that contraindicate injection therapy, such as bleeding diathesis
* Known history of allergy or anaphylaxis to drugs used in treatment
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Istanbul University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Fatmanur Yegin
Research Assistant Doctor
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023/890
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.